UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

1-LB: Advancing Therapy in Basal Insulin Users with Type 2 Diabetes (T2D): Hypoglycemia as a Function of HbA1c in the SoliMix Trial

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

118-LB: Efficacy and Safety of iGlarLixi vs. IDegAsp: Systematic Review and Indirect Treatment Comparison (ITC)

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

14. Glycemic control and hypoglycemia with new insulin glargine 300 U/mL in people with T1DM (EDITION 4) (80-LB (late breaking))

Nederlands Tijdschrift voor Diabetolog, 2014-10, Vol.12 (4), p.17-18

2014

Volltextzugriff (PDF)

(20) Improved cardiovascular outcomes with dpp-4 inhibitors in diabetes – a meta-analysis

Atherosclerosis, 2012-08, Vol.223 (2), p.533-533

Home, Philip

2012

Volltextzugriff (PDF)

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

European heart journal, 2020-01, Vol.41 (2), p.255-323

2020

Volltextzugriff (PDF)

2020 vision – An overview of prospects for diabetes management and prevention in the next decade

Diabetes research and clinical practice, 2018-09, Vol.143, p.101-112

2018

Volltextzugriff (PDF)

A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naïve People With Type 2 Diabetes

Diabetes care, 2006-06, Vol.29 (6), p.1269-1274

2006

Volltextzugriff (PDF)

26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naïve People With Type 2 Diabetes

Diabetes care, 2006-06, Vol.29 (6), p.1269-1274

2006

Volltextzugriff (PDF)

5 The measurement of metabolite exchange across muscle beds

Baillière's clinical endocrinology and metabolism, 1987, Vol.1 (4), p.863-878

1987

Volltextzugriff (PDF)

8. The Impact of Diabetes Duration on Safety and Effectiveness of Insulin Analogs in Insulin-Naïve People with Type 2 Diabetes (885-P)

Nederlands Tijdschrift voor Diabetolog, 2014-10, Vol.12 (4), p.11-12

2014

Volltextzugriff (PDF)

845-P: Advancing Therapy in Basal Insulin–Treated Type 2 Diabetes: Exploratory Analysis of the SoliMix Trial by Baseline HbA1c, Insulin Dose, and BMI

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

846-P: Advancing Therapy in Basal Insulin–Treated Type 2 Diabetes: Exploratory Analysis of the SoliMix Trial by Baseline Age, Diabetes Duration, and Renal Function

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

959-P: Indirect Treatment Comparison (ITC) of IGlarLixi vs. IDegLira in Adults Inadequately Controlled by GLP-1 Receptor Agonists (GLP-1RAs)

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by Established Basal Insulin

Diabetes care, 2013-09, Vol.36 (9), p.2489-2496

2013

Volltextzugriff (PDF)

Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by Established Basal Insulin: A 24-week, randomized, placebo-controlled comparison (GetGoal-L)

Diabetes care, 2013-09, Vol.36 (9), p.2489-2496

2013

Volltextzugriff (PDF)

Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors' Expert Forum

Diabetes care, 2015-08, Vol.38 (8), p.1567

2015

Volltextzugriff (PDF)

Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors' Expert Forum

Diabetes care, 2015-08, Vol.38 (8), p.1567-1582

2015

Volltextzugriff (PDF)

An analysis of the cost-effectiveness of starting insulin detemir in insulin-naïve people with type 2 diabetes

Journal of medical economics, 2015-03, Vol.18 (3), p.230-240

2015

Volltextzugriff (PDF)

An analysis of the short- and long-term cost-effectiveness of starting biphasic insulin aspart 30 in insulin-naïve people with poorly controlled type 2 diabetes

Diabetes research and clinical practice, 2014-11, Vol.106 (2), p.319-327

2014

Volltextzugriff (PDF)

The Authors??? Reply

PharmacoEconomics, 2006, Vol.24 (9), p.929-935

2006

Volltextzugriff (PDF)

The Authors' Reply

PharmacoEconomics, 2006, Vol.24 (9), p.929-935

2006

Volltextzugriff (PDF)

Between the Devil and the Deep Blue Hypo

Diabetic medicine, 1991-04, Vol.8 (3), p.277-277

Home, Philip

1991

Volltextzugriff (PDF)

Beyond Metformin: Safety Considerations in the Decision-Making Process for Selecting a Second Medication for Type 2 Diabetes Management

Diabetes care, 2014-09, Vol.37 (9), p.2647-2659

2014

Volltextzugriff (PDF)

Beyond Metformin: Safety Considerations in the Decision-Making Process for Selecting a Second Medication for Type 2 Diabetes Management: Reflections From a

Diabetes care, 2014-08, Vol.37 (9), p.2647-2659

2014

Volltextzugriff (PDF)

Beyond Metformin: Safety Considerations in the Decision-Making Process for Selecting a Second Medication for Type 2 Diabetes Management Reflections From a Diabetes Care Editors' Expert Forum

Diabetes care, 2014-09, Vol.37 (9), p.2647-2659

2014

Volltextzugriff (PDF)

1 – 25 von 302

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(256)
Mit Volltextzugriff
(218)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(172)
Life Sciences & Biomedicine
(171)
Humans
(157)
Endocrinology & Metabolism
(128)
Diabetes
(79)
Female
(66)
Male
(65)
Diabetes Mellitus, Type 2 - Drug Therapy
(54)
Insulin
(53)
Middle Aged
(49)
Hypoglycemic Agents - Therapeutic Use
(46)
Biological And Medical Sciences
(43)
Medical Sciences
(43)
Adult
(42)
Diabetes Mellitus
(39)
Hypoglycemia
(38)
Insulin - Therapeutic Use
(34)
Blood Glucose - Metabolism
(29)
Type 2 Diabetes
(28)
Aged
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

1-LB: Advancing Therapy in Basal Insulin Users with Type 2 Diabetes (T2D): Hypoglycemia as a Function of HbA1c in the SoliMix Trial

118-LB: Efficacy and Safety of iGlarLixi vs. IDegAsp: Systematic Review and Indirect Treatment Comparison (ITC)

14. Glycemic control and hypoglycemia with new insulin glargine 300 U/mL in people with T1DM (EDITION 4) (80-LB (late breaking))

(20) Improved cardiovascular outcomes with dpp-4 inhibitors in diabetes – a meta-analysis

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

2020 vision – An overview of prospects for diabetes management and prevention in the next decade

A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naïve People With Type 2 Diabetes

26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naïve People With Type 2 Diabetes

5 The measurement of metabolite exchange across muscle beds

8. The Impact of Diabetes Duration on Safety and Effectiveness of Insulin Analogs in Insulin-Naïve People with Type 2 Diabetes (885-P)

845-P: Advancing Therapy in Basal Insulin–Treated Type 2 Diabetes: Exploratory Analysis of the SoliMix Trial by Baseline HbA1c, Insulin Dose, and BMI

846-P: Advancing Therapy in Basal Insulin–Treated Type 2 Diabetes: Exploratory Analysis of the SoliMix Trial by Baseline Age, Diabetes Duration, and Renal Function

959-P: Indirect Treatment Comparison (ITC) of IGlarLixi vs. IDegLira in Adults Inadequately Controlled by GLP-1 Receptor Agonists (GLP-1RAs)

Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by Established Basal Insulin

Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by Established Basal Insulin: A 24-week, randomized, placebo-controlled comparison (GetGoal-L)

Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors' Expert Forum

Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors' Expert Forum

An analysis of the cost-effectiveness of starting insulin detemir in insulin-naïve people with type 2 diabetes

An analysis of the short- and long-term cost-effectiveness of starting biphasic insulin aspart 30 in insulin-naïve people with poorly controlled type 2 diabetes

The Authors??? Reply

The Authors' Reply

Between the Devil and the Deep Blue Hypo

Beyond Metformin: Safety Considerations in the Decision-Making Process for Selecting a Second Medication for Type 2 Diabetes Management

Beyond Metformin: Safety Considerations in the Decision-Making Process for Selecting a Second Medication for Type 2 Diabetes Management: Reflections From a

Beyond Metformin: Safety Considerations in the Decision-Making Process for Selecting a Second Medication for Type 2 Diabetes Management Reflections From a Diabetes Care Editors' Expert Forum

Suchergebnisse filtern